What blood glucose range is safe for initiating thrombolytic therapy (alteplase)?

Blood Glucose Levels for Prethrombolysis with Alteplase

IV alteplase is recommended for acute ischemic stroke patients with initial glucose levels >50 mg/dL (>2.8 mmol/L), and there is no upper glucose threshold that absolutely contraindicates thrombolysis. 1

Safe Blood Glucose Range

The 2018 AHA/ASA Guidelines provide clear direction on glucose parameters for alteplase administration:

• Lower threshold: Blood glucose must be >50 mg/dL to proceed with thrombolysis 1
• Upper threshold: No absolute contraindication exists for hyperglycemia, though outcomes worsen with higher glucose levels

Before administering alteplase, you must determine blood glucose levels to exclude hypoglycemia and hyperglycemia that may mimic stroke presentations. 1 This is critical because hypoglycemia can present identically to acute stroke, and alteplase is not indicated for non-vascular conditions.

Clinical Context and Outcomes

While hyperglycemia doesn't contraindicate thrombolysis, it significantly impacts prognosis:

Optimal glucose range for best outcomes:

Research demonstrates that blood glucose between 7.0-9.0 mmol/L (126-162 mg/dL) before thrombolysis yields the highest efficacy rate of 73.9% in diabetic patients 2. Efficacy decreases substantially when glucose is <6.0 mmol/L (33.3% efficacy) or progressively rises above 9.0 mmol/L 2.

Hyperglycemia consequences:

• Blood glucose >140 mg/dL (>7.8 mmol/L) significantly increases risk of:

  • Symptomatic intracranial hemorrhage (OR 1.80) 3
  • Poor clinical outcome at 90 days (OR 1.82) 3
  • All-cause mortality at 90 days (OR 2.51) 3

• Impaired fasting glucose (≥5.6 mmol/L or ≥100 mg/dL) predicts worse outcomes better than admission hyperglycemia alone (adjusted OR 2.77 vs 1.75) 4

• Normal pretreatment blood glucose is an independent predictor of good outcome 5

Practical Algorithm

1. Check blood glucose immediately upon stroke presentation
2. If glucose <50 mg/dL: Treat hypoglycemia first; do NOT give alteplase until corrected and stroke symptoms persist
3. If glucose 50-140 mg/dL: Proceed with alteplase if other criteria met (optimal range)
4. If glucose >140 mg/dL: Still proceed with alteplase if within time window—do NOT delay treatment to lower glucose 1, but anticipate higher hemorrhage risk and worse outcomes
5. If glucose >180 mg/dL persistently or extreme hyperglycemia: Consider IV insulin protocol during and after thrombolysis 6

Critical Pitfalls to Avoid

• Never delay alteplase to "correct" hyperglycemia—time to treatment is paramount and strongly associated with outcomes 1
• Do not assume stroke symptoms in hypoglycemic patients—always check glucose to avoid inappropriate thrombolysis for a metabolic mimic 1
• Diabetes history alone does not contraindicate thrombolysis—proceed with standard dosing, though outcomes may be less favorable 2, 7

The guideline is unequivocal: only glucose ≤50 mg/dL is a contraindication. All other glucose values permit thrombolysis, though higher values correlate with progressively worse outcomes.